FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields

FGFR inhibition as a new therapeutic strategy to sensitize glioblastoma stem cells to tumor treating fields

Abstract Glioblastomas (GBM) are aggressive tumors, which systematically relapse despite standard treatment associating surgery, chemotherapy and radiation therapy. More recently, GBM therapy now includes another therapeutic modality option, Tumor Treating Fields (TTFields) given in combination with...

Full description

Saved in:
Bibliographic Details
Main Authors: Pauline Deshors, Ziad Kheil, Laetitia Ligat, Valerie Gouazé-Andersson, Elizabeth Cohen-Jonathan Moyal
Format: Article
Language:English
Published: Nature Publishing Group 2025-06-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02542-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items